Rishi Singhal, MD
Retina Specialist · Peachtree Corners, GANPI 1427412550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Harrow Eye, LLC at 31.2% of the total.
Across 38 payments — averaging $35.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harrow Eye, LLC$418
- Alcon$174
- Bausch & Lomb Americas Inc.$114
- AbbVie$100
- Apellis Pharmaceuticals, Inc.$88
- Mallinckrodt Hospital Products Inc.$87
- plus $358 from 8 others
What the payments were for
- Food & beverage$1,27395%
- Entertainment$675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harrow Eye, LLC | 5 | $418 |
| Alcon | 2 | $174 |
| Bausch & Lomb Americas Inc. | 6 | $114 |
| AbbVie | 4 | $100 |
| Apellis Pharmaceuticals, Inc. | 3 | $88 |
| Mallinckrodt Hospital Products Inc. | 4 | $87 |
| Genentech USA, Inc. | 3 | $87 |
| Alimera Sciences, Inc. | 4 | $78 |
| Optos, Inc. | 1 | $67 |
| ANI Pharmaceuticals, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $27 |
| Coherus Oncology, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few retina specialist providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 76 | $4,101 |
| Brimonidine Tartrate | 39 | $1,954 |
| Dorzolamide Hcl | 57 | $1,101 |
| Latanoprost | 89 | $734 |
| Atropine Sulfate | 17 | $645 |
| Ketorolac Tromethamine | 30 | $588 |
| Ofloxacin | 33 | $435 |
| Timolol Maleate | 25 | $254 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Peachtree Corners
- David Chin YeeAtlanta$816K
- Daniel OhAtlanta$58K
- Sruthi ArepalliAtlanta$30K
- Ranjit DhaliwalAugusta$18K
- Oksana DemediukAugusta$16K
- Alexander BottiniBraselton$7K
- Kareem SioufiMarietta$6K
- James FrankAtlanta$4K
- Dimple ModiRome$3K
- Sohail KhanAugusta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.